Chimerix reported $291.12M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Ardelyx ARDX:US USD 119.88M 5.77M
Chimerix CMRX:US USD 291.12M 240.35M
Curis CRIS:US USD 105.72M 7.68M
Emergent Biosolutions EBS:US USD 1.12B 34.3M
Gilead Sciences GILD:US USD 13.9B 723M
Glaxosmithkline GSK:US GBP 20.25B 33.94B
Life Technologies LIFE:US USD 84.63M 8.72M
Mirati Therapeutics MRTX:US USD 1.23B 22.86M
Novavax NVAX:US USD 1.76B 376.04M
Xoma XOMA:US USD 79.74M 7.52M